Zobrazeno 1 - 10
of 17
pro vyhledávání: '"J. R. Germà Lluch"'
Autor:
J. Masip, J. R. Germà Lluch
Publikováno v:
Revista Clínica Española. 221:359-368
Resumen Estudios epidemiologicos recientes han demostrado que el consumo de alcohol puede aumentar el riesgo de hipertension arterial, fibrilacion auricular y de cancer digestivo y de mama, por lo que diversos estamentos estan promoviendo la abstinen
Autor:
J. R. Germà Lluch, J. Masip
Publikováno v:
Revista Clínica Española (English Edition). 221:359-368
Recent epidemiological studies have shown that alcohol consumption can increase the risk of arterial hypertension, atrial fibrillation and gastrointestinal and breast cancer. Various sectors are therefore promoting abstinence from alcohol. However, l
Autor:
Ahmad Awada, Jan B. Vermorken, J. R. Germà-Lluch, Ioannis S. Pateras, Amanda Psyrri, M. Degardin, Christos Kroupis, Catherine Fortpied, Margaritis Avgeris, Heinz Roland Kienzer, Jessica Menis, George Koutsodontis, L. Herman, Nikolaos Goutas, Lisa Licitra, Johannes A. Langendijk, Livia Giurgea, Éva Remenár, C.M.L. van Herpen
Publikováno v:
Annals of Oncology, 28, 2213-2218
Annals of Oncology, 28(9), 2213-2218. Oxford University Press
Annals of Oncology, 28, 9, pp. 2213-2218
Annals of oncology
Annals of oncology, 28 (9
Annals of Oncology, 28(9), 2213-2218. Oxford University Press
Annals of Oncology, 28, 9, pp. 2213-2218
Annals of oncology
Annals of oncology, 28 (9
Background: EORTC 24971 was a phase III trial demonstrating superiority of induction regimen TPF (docetaxel, cisplatin, 5-fluorouracil) over PF (cisplatin/5-fluorouracil), in terms of progression-free (PFS) and overall survival (OS) in locoregionally
Autor:
J. R. Germà Lluch, F. Losa Gaspà, A. Martos Rodríguez, J. M. Albareda Boleda, B. Sanuy Jiménez, L. Camacho Cuartero, R. Niubó Daniel
Publikováno v:
Revista Clínica Española. 202:604-614
Autor:
F, Losa Gaspà, J R, Germà Lluch, L, Camacho Cuartero, R, Niubó Daniel, J M, Albareda Boleda, B, Sanuy Jiménez, A, Martos Rodríguez
Publikováno v:
Revista clinica espanola. 202(11)
Publikováno v:
Archivos espanoles de urologia. 53(6)
To discuss briefly the new therapeutic strategies for poor-prognosis testicular germ cell cancer.The use of new drugs in first line chemotherapy, intensive alternating and sequential chemotherapy and high dose chemotherapy with autologous bone marrow
Publikováno v:
Archivos espanoles de urologia. 53(6)
To review the treatment of stage I nonseminomatous germ cell testicular tumor with adjuvant chemotherapy.The literature on this subject was reviewed.Overall, 30% of stage I nonseminomatous germ cell testicular tumors that are followed recur within tw
Autor:
M A, Climent, C, Pallarés Curto, R, Blanco Guerrero, J M, Seguí Palmer, J R, Germà Lluch, L, de Andrés Basauri, J J, López López
Publikováno v:
Medicina clinica. 97(15)
Non-Hodgkin's lymphomas (NHL) originated in the otorhinolaryngological (ORL) area are rare diseases and its therapy is poorly established.The diagnostic features, treatment and outcome based on therapy of 34 NHLs originated in the ORL area and seen i
Autor:
R, Blanco Guerrero, J R, Germà Lluch, M A, Climent Durán, A, Mercedes Ramírez, C, Alonso Muñoz, A, López Pousa, J J, López López
Publikováno v:
Medicina clinica. 97(13)
The reduction of iatrogenesis is fundamental in the treatment of germ-cell testicular tumors (GTT) because of the high incidence of cures achieved. On the other hand, the tumoral mass and the serum concentration of the beta fraction of the gonadotrop
Autor:
M. Martinez Villacampa, X. Perez, G. Soler, Carlos Ferreira dos Santos, E. Kreissler, A. Pisa, R. Salazar, J. R. Germà Lluch, Berta Laquente, Mariona Calvo
Publikováno v:
Journal of Clinical Oncology. 26:15051-15051
15051 Background: Peritoneal carcinomatosis (PC) is a poor prognostic complication for colorrectal cancer (CRC). Peritoneal surgery and intraperitoneal chemotherapy achieve 12–34 months OS in phase II-III trials. The most important criteria for pat